The 20 Best Triple-Negative Breast Cancer Doctors Near Me in Houston, TX
Find the Top Triple-Negative Breast Cancer Experts and Specialists
Baylor St. Luke's - O’Quinn Medical Tower At McNair
Dr. Alastair Thompson is a surgical oncologist specializing in breast cancer. He is the Professor and Chief of the Division of Surgical Oncology, Section of Breast Surgery at Baylor College of Medicine, where he holds the Olga Keith Wiess Chair of Surgery. He also serves as Co-Director of the Lester and Sue Smith Breast Center and is Co-Associate Director for Clinical Research at the Dan L Duncan Comprehensive Cancer Center.Dr. Thomspon’s clinical interests include: ductal carcinoma in situ (DCIS); nipple and skin sparing mastectomy; breast conservation surgery; and sentinel lymph node biopsy. His research interests include: multidisciplinary patient care alongside “bench to bedside” studies; and innovative clinical trials in cancer. He initiated and led a successful breast cancer laboratory program; provided leadership for a cancer center in the United Kingdom; chaired the UK national breast cancer trials portfolio of 120 studies; and engaged in a range of pivotal roles in key drug, radiation therapy and surgical trials involving the UK, Europe, United States and Australia.Dr. Thompson also has preclinical and practical experience in the design, implementation, monitoring and reporting of early- to late-phase drug and medical device trials. Dr. Thompson received his MBChB in Medicine Surgery and medical degree in Molecular Biology from the University of Edinburgh in Edinburgh, Scotland. He completed his residency in general surgery at the Royal Infirmary of Edinburgh and a Research Fellowship at the Imperial Cancer Research Fund in Edinburgh.Dr. Thompson has co-chaired the Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial for low-risk DCIS; and the National Cancer Institute (NCI)-Breast Cancer Steering Committee proposed “no surgery” clinical trial planning committee. He is a member of the NCI BOLD taskforce and has held leadership positions in the Translational Breast Cancer Research Consortium and SWOG Cancer Research Network.Dr. Thompson is also a member of the American Society of Clinical Oncology, Association of Breast Surgery, British Association of Surgical Oncology, British Breast Group, American Society of Breast Surgeons, American Association for Cancer Research, Moynihan Chirurgical Club, and the Society of Surgical Oncology. Dr. Thompson is rated as an Elite provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, Mastectomy, and Tissue Biopsy. Dr. Thompson is currently accepting new patients.
UT MD Anderson Cancer Center
Jennifer Litton is an Oncologist practicing medicine in Houston, Texas. Dr. Litton is rated as an Elite provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, and Paget Disease of the Breast.
Office
Bora Lim is a Hematologist practicing medicine in Houston, Texas. Dr. Lim is rated as an Elite provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Inflammatory Breast Cancer, Breast Cancer, Triple-Negative Breast Cancer, and Paget Disease of the Breast.
Baylor College Of Medicine
Dr. Mothaffar F. Rimawi is a board-certified medical oncologist specializing in breast cancer care and research. He is Professor at the Department of Medicine, Section of Hematology and Oncology at Baylor College of Medicine. Dr. Rimawi is also Executive Medical Director & Associate Director of Clinical Affairs and Co-Leader of the Breast Cancer Program at BCM’s Dan L Duncan Comprehensive Cancer Center. Additionally, he serves as Chief of the Oncology Service Line at St Luke's Health in Houston.Dr. Rimawi’s professional interests include: the diagnosis, treatment and management of breast cancer; clinical trials in breast cancer; neoadjuvant therapy; targeted therapy and biomarkers in breast cancer; treatment resistance to ER and HER2-targeted therapies in breast cancer; locally advanced breast cancer; and breast disease and cancer.Dr. Rimawi received his medical degree from the University of Jordan in Amman, Jordan. He completed his residency in Internal Medicine and fellowships in Medical Oncology and Hematology and Breast Cancer at BCM. Dr. Rimawi holds certifications in Internal Medicine and Medical Oncology from the American Board of Internal Medicine. He is a member of the American College of Physicians, American Society of Clinical Oncology and the American Medical Association.In addition to English, Dr. Rimawi speaks Arabic. Dr. Rimawi is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Triple-Negative Breast Cancer, and Paget Disease of the Breast. Dr. Rimawi is currently accepting new patients.
MD Anderson
Funda Meric is a General Surgeon and a Surgical Oncologist practicing medicine in Houston, Texas. Dr. Meric is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses PIK3CA-Related Overgrowth Spectrum, Breast Cancer, Cholangiocarcinoma (Bile Duct Cancer), Triple-Negative Breast Cancer, and Mastectomy.
Baylor College Of Medicine
Dr. Ahmed Elkhanany specializes in the care of patients with breast cancer. He is an Assistant Professor of Medicine at the Lester and Sue Smith Breast Center at Baylor College of Medicine, where he is also a member of the Breast Cancer Prevention and High-Risk Clinic.Dr. Elkhanany’s clinical interests include breast cancer prevention and metastatic breast cancer. His research interests include: translational breast cancer genomics and impact of race and ethnicity on gene drivers of breast cancer. He is also involved with projects that translate lab-based findings to bedside novel treatment combinations in the hope of improving patient lives and finding novel, less toxic cures.Dr. Elkhanany received his medical degree from the Alexandria University School of Medicine in Egypt. He completed his residency in internal medicine at the University of Missouri-Kansas City and a fellowship in hematology and oncology at Roswell Park Comprehensive Cancer Center in Buffalo, New York. He also completed a post-doctoral felllowship in Triple Negative Breast Cancer at Mayo Clinic in Rochester, Minnesota.A member of the American Society of Clinical Oncology Dr. Elkhanany is board certified in internal medicine, hematology, and oncology. He is also the recipient of several teaching awards at the University of Alabama (UAB) at Birmingham, where he was previously Assistant Professor in the Department of Breast Oncology at UAB Medicine.In addition to English, Dr. Elkhanany speaks Arabic. Dr. Elkhanany is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Tissue Biopsy. Dr. Elkhanany is currently accepting new patients.
UT MD Anderson Cancer Center
Nuhad Ibrahim is an Oncologist practicing medicine in Houston, Texas. Dr. Ibrahim is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, HER2 Negative Breast Cancer, and Triple-Negative Breast Cancer.
UT MD Anderson Cancer Center
Powel Brown is an Internal Medicine provider practicing medicine in Houston, Texas. Dr. Brown is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Salpingo-Oophorectomy.
Office
Carlos Barcenas is an Oncologist practicing medicine in Houston, Texas. Dr. Barcenas is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Triple-Negative Breast Cancer, Paget Disease of the Breast, and Colonoscopy.
Office
Gabriel Hortobagyi is an Oncologist practicing medicine in Houston, Texas. Dr. Hortobagyi is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Triple-Negative Breast Cancer, and Breast Cancer in Men.
Houston Methodist Radiation Oncology Group
Alice Ho is a Family Medicine provider practicing medicine in Houston, Texas. Dr. Ho is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Angiosarcoma, and Ataxia-Telangiectasia.
UT MD Anderson Cancer Center
Hussein Tawbi is an Oncologist practicing medicine in Houston, Texas. Dr. Tawbi is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Melanoma, Metastatic Brain Tumor, Brain Tumor, Adult Soft Tissue Sarcoma, and Gamma Knife Radiosurgery.
Office
Mary Guirguis is a Radiologist practicing medicine in Houston, Texas. She has been practicing medicine for over 10 years. Dr. Guirguis is rated as an Experienced provider by MediFind in the treatment of Triple-Negative Breast Cancer. Her clinical expertise encompasses Triple-Negative Breast Cancer, Breast Cancer, Galactocoele, and Breast Lump.
Office
Simona Shaitelman is a Radiation Oncologist practicing medicine in Houston, Texas. Dr. Shaitelman is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Intraductal Papilloma, and Angiosarcoma.
Baylor College Of Medicine
Dr. Julie Nangia is a medical oncologist who specializes in the care of patients with breast cancer. Dr. Nangia is Medical Director of Breast Oncology at the Breast Care Center at the Dan L Duncan Comprehensive Cancer Center and an Associate Professor of Medicine at the Lester and Sue Smith Breast Center at Baylor College of Medicine. She is also the Director of the Breast Cancer Prevention and High Risk Clinic at BCM, where she is a Faculty Senator.Dr. Nangia’s clinical interests include: hereditary breast cancer, breast cancer prevention, and metastatic triple negative breast cancer.Dr. Nangia received her medical degree from the University of Missouri-Kansas City. She completed her residency in internal medicine at The University of Texas Health Science Center in Houston and a hematology-oncology fellowship at Rush University Medical Center in Chicago, Illinois.Dr. Nangia is board certified in internal medicine and medical oncology. Dr. Nangia is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Familial Pancreatic Cancer, and HER-2 Positive Breast Cancer. Dr. Nangia is currently accepting new patients.
Dr. Shalini Makawita is an oncologist specializing in gastrointestinal and general medical oncology. She is Assistant Professor of Medicine - Hematology & Oncology at the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine.Dr. Makawita’s clinical interests include: gastrointestinal medical oncology; clinical trials; and cancer biomarkers.Dr. Makawita received a B.S. and MSc from the University of Toronto. She received her medical degree from Wayne State University School of Medicine. She completed her residency in internal medicine at Baylor College of Medicine and a fellowship in Hematology and Oncology at M.D. Anderson Cancer Center.Dr. Makawita holds certifications from the American Board of Internal Medicine in Medical Oncology and Hematology. She is a member of the American Society of Clinical Oncology and American Society of Hematology. In 2021, Dr. Makawita received the ASCO Conquer Cancer Merit Award and an Excellence in Ambulatory Care commendation in 2018 from Baylor College of Medicine. Dr. Makawita is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Triple-Negative Breast Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Cancer, and Gastrointestinal Stromal Tumor. Dr. Makawita is currently accepting new patients.
Dr. Michelle Ludwig is a radiation oncologist. She is an Associate Professor of Radiation Oncology at the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine. She is also an Adjunct Assistant Professor of Human Genetics & Environmental Sciences, Division of Epidemiology at the UTHealth School of Public Health in Houston.Dr. Ludwig completed undergraduate studies at Purdue University in Lafayette, Indiana and received her medical degree from Emory University School of Medicine in Atlanta. She received her MPH from the Emory Rollins School of Public Health in Atlanta and her Ph.D. from the University of Texas Health Science Center in Houston. She completed her residency at the M.D. Anderson Cancer Center and a clinical fellowship at The University of Texas, Houston Medical Program and M.D. Anderson Cancer Center. Dr. Ludwig is board-certified in Radiation Oncology by the American Board of Radiology. In addition to English, Dr. Ludwig speaks Spanish. Dr. Ludwig is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Cervical Cancer, Triple-Negative Breast Cancer, Neuroendocrine Carcinoma of the Cervix, and Breast Cancer. Dr. Ludwig is currently accepting new patients.
UT MD Anderson Cancer Center
Diana Liang is a General Surgeon practicing medicine in Houston, Texas. Dr. Liang is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Triple-Negative Breast Cancer, Pancreaticoduodenectomy, and Stent Placement.
UT MD Anderson Cancer Center
Amal Melhem is a primary care provider, practicing in Internal Medicine in Houston, Texas. Dr. Melhem is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Triple-Negative Breast Cancer and Breast Cancer.
UT MD Anderson Cancer Center
Welela Tereffe is a Radiation Oncologist practicing medicine in Houston, Texas. Dr. Tereffe is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Intraductal Papilloma, and Mediastinal Tumor.
Last Updated: 04/28/2026







